Intensity Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Update

/PRNewswire/ -- Intensity Therapeutics, Inc. ("Intensity" or "the Company") (Nasdaq: INTS), a late-stage clinical biotechnology company focused on the...

Aug 11, 2026 - 15:00
 0  1
Intensity Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Update
/PRNewswire/ -- Intensity Therapeutics, Inc. ("Intensity" or "the Company") (Nasdaq: INTS), a late-stage clinical biotechnology company focused on the...

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow